Evidence map›Paper›PMID 22136135›Full record

ArticleJournal of neuroinflammation2011

Neuropeptide Y inhibits interleukin-1β-induced phagocytosis by microglial cells.

Raquel Ferreira, Tiago Santos, Michelle Viegas, Luísa Cortes, Liliana Bernardino, Otília V Vieira, João O Malva

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Mettl3-mCell discovery · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Lung Fibrosis Finds an Unsung Hero in Neuropeptide Y.American journal of respiratory cell and molecular biology · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Neuropeptide Y attenuates cardiac remodeling and deterioration of function following myocardial infarction.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  16. Review
  17. Article
  18. The Role of Neuropeptides in Pathogenesis of Dry Dye.Journal of clinical medicine · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Raquel FerreiraCenter for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal. ferreira@cnc.cj.uc.pt
Tiago Santos
Michelle Viegas
Luísa Cortes
Liliana Bernardino
Otília V Vieira
João O Malva
University of Coimbra · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuropeptide Y (NPY) is emerging as a modulator of communication between the brain and the immune system. However, in spite of increasing evidence that supports a role for NPY in the modulation of microglial cell responses to inflammatory conditions, there is no consistent information regarding the action of NPY on microglial phagocytic activity, a vital component of the inflammatory response in brain injury. Taking this into consideration, we sought to assess a potential new role for NPY as a modulator of phagocytosis by microglial cells.

methodsThe N9 murine microglial cell line was used to evaluate the role of NPY in phagocytosis. For that purpose, an IgG-opsonized latex bead assay was performed in the presence of lipopolysaccharide (LPS) and an interleukin-1β (IL-1β) challenge, and upon NPY treatment. A pharmacological approach using NPY receptor agonists and antagonists followed to uncover which NPY receptor was involved. Moreover, western blotting and immunocytochemical studies were performed to evaluate expression of p38 mitogen-activated protein kinase (MAPK) and heat shock protein 27 (HSP27), in an inflammatory context, upon NPY treatment.

resultsHere, we show that NPY inhibits phagocytosis of opsonized latex beads and inhibits actin cytoskeleton reorganization triggered by LPS stimulation. Co-stimulation of microglia with LPS and adenosine triphosphate also resulted in increased phagocytosis, an effect inhibited by an interleukin-1 receptor antagonist, suggesting involvement of IL-1β signaling. Furthermore, direct application of LPS or IL-1β activated downstream signaling molecules, including p38 MAPK and HSP27, and these effects were inhibited by NPY. Moreover, we also observed that the inhibitory effect of NPY on phagocytosis was mediated via Y1 receptor activation.

conclusionsAltogether, we have identified a novel role for NPY in the regulation of microglial phagocytic properties, in an inflammatory context.

Indexed as

AnimalsCell LineCytoskeletonHSP27 Heat-Shock ProteinsHumansInflammationInterleukin-1betaLipopolysaccharidesMiceMicrogliaNeuropeptide Yp38 Mitogen-Activated Protein KinasesPhagocytosisReceptors, IgGReceptors, Neuropeptide YSignal TransductionFc gamma receptor IIAHSP27 Heat-Shock ProteinsInterleukin-1betaLipopolysaccharidesNeuropeptide Yneuropeptide Y-Y1 receptorp38 Mitogen-Activated Protein KinasesReceptors, IgGReceptors, Neuropeptide Y

Identifiers

PMID22136135
PMCPMC3239417
OpenAlexW2164798123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.